RA Capital Management
Major shareholder at Vor Biopharma · 172 reported transactions in 23 companies · latest trade Sep 17, 2026
Their record
Across their whole record, 8 purchases can be measured; 4 did better than the S&P 500 over the next 6 months.
Typical move +28.4%, S&P 500 +9.2% over the same days.
Their trades
Sold | Sep 17, 2026 | Sep 17, 2026 close $7.18 → Oct 29, 2026 close $4.00. S&P 500 +1.3% over the same days. | ||
Sold | Sep 17, 2026 | Sep 17, 2026 close $7.18 → Oct 29, 2026 close $4.00. S&P 500 +1.3% over the same days. | ||
Sold | Aug 12, 2026 | Aug 12, 2026 close $48.19 → Oct 29, 2026 close $45.23. S&P 500 −0.0% over the same days. | ||
Sold | Aug 12, 2026 | Aug 12, 2026 close $48.19 → Oct 29, 2026 close $45.23. S&P 500 −0.0% over the same days. | ||
Bought | Jul 31, 2026 | Jul 31, 2026 close $10.10 → Oct 29, 2026 close $4.23. S&P 500 +3.4% over the same days. | ||
Bought | Jul 29, 2026 | Jul 29, 2026 close $10.02 → Oct 29, 2026 close $4.23. S&P 500 +5.9% over the same days. |
$252.1K
Sep 17, 2026 close $7.18 → Oct 29, 2026 close $4.00. S&P 500 +1.3% over the same days.
$21.58M
Sep 17, 2026 close $7.18 → Oct 29, 2026 close $4.00. S&P 500 +1.3% over the same days.
SoldSepterna
$31.73M
Aug 12, 2026 close $48.19 → Oct 29, 2026 close $45.23. S&P 500 −0.0% over the same days.
SoldSepterna
$31.73M
Aug 12, 2026 close $48.19 → Oct 29, 2026 close $45.23. S&P 500 −0.0% over the same days.
BoughtArtiva Biotherapeutics
$247.7K
Jul 31, 2026 close $10.10 → Oct 29, 2026 close $4.23. S&P 500 +3.4% over the same days.
BoughtArtiva Biotherapeutics
$208K
Jul 29, 2026 close $10.02 → Oct 29, 2026 close $4.23. S&P 500 +5.9% over the same days.